🔎 Trials Near Me

መነሻ › የጡንቻ ካንሰር › ካሊፎርኒያ › Mountain View

በMountain View፣ CA ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 26 ጥናቶች በMountain View እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Stanford Women's Cancer Center, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06982521

A Study of PHST001 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Stanford University School of Medicine, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06840886

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • El Camino Hospital, Mountain View
  • Palo Alto Medical Foundation, Mountain View
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05827081

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Stanford Medicine Cancer Center, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07701941

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • El Camino Hospital Cancer Center ( Site 0096), Mountain View
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06966700

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Stanford University Medical Center, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Stanford University Medical Center, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Stanford Cancer Center, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Stanford Women's Cancer Center, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Stanford University Hospital, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05307705

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Palo Alto · 5 ማይል ርቀት
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07647328

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Stanford Cancer Institute, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07405801

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Palo Alto Medical Foundation Research Center, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Palo Alto Medical Foundation-Camino Division, Mountain View
  • Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
  • Palo Alto Medical Foundation Health Care, Palo Alto · 5 ማይል ርቀት
  • እና 1 ተጨማሪ
እድሜ ከ18 እስከ 60 · ሴቶች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05879926

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Stanford University, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT04768426

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Local Institution - 0358, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06926868

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · 5 ማይል ርቀት
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05232916

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Stanford University Medical Center, Palo Alto · 5 ማይል ርቀት
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT06562192

Magnetic Resonance Imaging of Breast Cancer

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Stanford University School of Medicine, Stanford · 5 ማይል ርቀት
እድሜ 21 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ1 ጁላይ 2026 · NCT01035112

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Stanford University School of Medicine, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ18 ሜይ 2026 · NCT01034033

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Palo Alto Medical Foundation-Camino Division, Mountain View
  • Palo Alto Medical Foundation Health Care, Palo Alto · 5 ማይል ርቀት
  • Stanford Cancer Institute Palo Alto, Palo Alto · 5 ማይል ርቀት
እድሜ ከ50 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ23 ኤፕሪ 2026 · NCT04852887

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Stanford Cancer Institute, Stanford · 5 ማይል ርቀት
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT04119024

Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

ተሳታዮችን በመፈለግ ላይ
  • Stanford University, Stanford · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ12 ማርች 2026 · NCT03909282

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Stanford Cancer Institute, Palo Alto · 5 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጃንዩ 2026 · NCT06401421

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Stanford · 5 ማይል ርቀት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች

በMountain View ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።